← Back to search

MEDPACE HOLDINGS, INC.

MEDP · NASDAQ

Research and Development in Biotechnology

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries.

ESG Scores

Overall ESG
3.8
Environmental
7.1
Social
4.7
Governance
4.6

Gender Diversity

Female Directors0.16670000000000001%
Female Executives0.12396694214876033%
Women in Workforce0.67%
CEO GenderMale

Market Data

Price$622.43+2.77 (+0.45%)
Market Cap$17.35B
P/E Ratio35.31
EPS$—
52W High$677.90
52W Low$373.00
Beta1.11